Axonics(AXNX) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Axonics Reports Second Quarter 2024 Financial Results Generated record revenue, gross margin and net income in 2Q24 IRVINE, Calif. – August 1, 2024 – Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops, manufactures and commercializes innovative and minimally invasive products to treat bladder and bowel dysfunction, today reported financial results for the three months ended June 30, 2024. "Axonics continued to execute at a high level in the second quarter, generating recor ...